Home LiteratureArticle Details
PMID: 9238046 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).

Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, Zeleznik-Le NJ

Abstract

The recurring translocation t(11;16)(q23;p13.3) has been documented only in cases of acute leukemia or myelodysplasia secondary to therapy with drugs targeting DNA topoisomerase II. We show that the MLL gene is fused to the gene that codes for CBP (CREB-binding protein), the protein that binds specifically to the DNA-binding protein CREB (cAMP response element-binding protein) in this translocation. MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP. Both fusion products retain the histone acetyltransferase domain of CBP and may lead to leukemia by promoting histone acetylation of genomic regions targeted by the MLL AT-hooks, leading to transcriptional deregulation via aberrant chromatin organization. CBP is the first partner gene of MLL containing well defined structural and functional motifs that provide unique insights into the potential mechanisms by which these translocations contribute to leukemogenesis.

MeSH Terms
Acute Disease Amino Acid Sequence Antineoplastic Agents/adverse effects,therapeutic use Base Sequence CREB-Binding Protein Chromosomes, Human, Pair 11 Chromosomes, Human, Pair 16 DNA-Binding Proteins/genetics Histone-Lysine N-Methyltransferase Humans Leukemia, Myeloid/drug therapy,genetics Molecular Sequence Data Myeloid-Lymphoid Leukemia Protein Nuclear Proteins/genetics Proto-Oncogenes Trans-Activators Transcription Factors/genetics Translocation, Genetic
Chemicals
Antineoplastic Agents DNA-Binding Proteins KMT2A protein, human Nuclear Proteins Trans-Activators Transcription Factors Myeloid-Lymphoid Leukemia Protein Histone-Lysine N-Methyltransferase CREB-Binding Protein CREBBP protein, human
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Sobulo O M
University of Chicago, Department of Medicine, Section of Hematology/Oncology, Chicago, IL 60637-1470, USA.
Borrow J
Tomek R
Reshmi S
Harden A
Schlegelberger B
Housman D
Doggett N A
Rowley J D
Zeleznik-Le N J
References (52)
52 references, click to expand
  1. The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene.
    Blood. 1997 Jun 1;89(11):3945-50 PMID: 9166831
  2. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator.
    Science. 1997 Jan 24;275(5299):523-7 PMID: 8999795
  3. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
    Blood. 1997 Jul 15;90(2):535-41 PMID: 9226152
  4. Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation.
    Genes Chromosomes Cancer. 1997 Sep;20(1):60-3 PMID: 9290955
  5. Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome.
    Am J Dis Child. 1963 Jun;105:588-608 PMID: 13983033
  6. The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure.
    J Biol Chem. 1990 May 25;265(15):8573-82 PMID: 1692833
  7. Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome.
    Proc Natl Acad Sci U S A. 1990 Dec;87(23):9358-62 PMID: 2251277
  8. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias.
    Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10735-9 PMID: 1720549
  9. Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations.
    Cancer Res. 1991 Dec 15;51(24):6712-4 PMID: 1835902
  10. brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2.
    Cell. 1992 Feb 7;68(3):561-72 PMID: 1346755
  11. The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins.
    Nucleic Acids Res. 1992 May 25;20(10):2603 PMID: 1350857
  12. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.
    Cell. 1992 Nov 13;71(4):691-700 PMID: 1423624
  13. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene.
    Cell. 1992 Nov 13;71(4):701-8 PMID: 1423625
  14. Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations.
    Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11794-8 PMID: 1465401
  15. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias.
    Nat Genet. 1992 Oct;2(2):113-8 PMID: 1303259
  16. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.
    Blood. 1993 Jun 15;81(12):3197-203 PMID: 8389614
  17. Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases.
    Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6350-4 PMID: 8327517
  18. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product.
    Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7884-8 PMID: 7689231
  19. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.
    N Engl J Med. 1993 Sep 23;329(13):909-14 PMID: 8361504
  20. Phosphorylated CREB binds specifically to the nuclear protein CBP.
    Nature. 1993 Oct 28;365(6449):855-9 PMID: 8413673
  21. HAT3.1, a novel Arabidopsis homeodomain protein containing a conserved cysteine-rich region.
    Plant J. 1993 Jul;4(1):137-50 PMID: 8106082
  22. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
    J Clin Oncol. 1993 Dec;11(12):2370-9 PMID: 8246025
  23. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
    Blood. 1993 Dec 15;82(12):3705-11 PMID: 8260707
  24. Rearrangements involving chromosome band 11Q23 in acute leukaemia.
    Semin Cancer Biol. 1993 Dec;4(6):377-85 PMID: 8142623
  25. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation.
    Blood. 1994 May 15;83(10):2780-6 PMID: 8180374
  26. Nuclear protein CBP is a coactivator for the transcription factor CREB.
    Nature. 1994 Jul 21;370(6486):223-6 PMID: 7913207
  27. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor.
    Nature. 1994 Jul 21;370(6486):226-9 PMID: 8028671
  28. 11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene.
    Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10610-4 PMID: 7938000
  29. Tumors in Rubinstein-Taybi syndrome.
    Am J Med Genet. 1995 Mar 13;56(1):112-5 PMID: 7747773
  30. The human MLL gene: nucleotide sequence, homology to the Drosophila trx zinc-finger domain, and alternative splicing.
    DNA Cell Biol. 1995 Jun;14(6):475-83 PMID: 7598802
  31. Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations.
    Genes Chromosomes Cancer. 1995 Jun;13(2):75-85 PMID: 7542910
  32. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.
    Nature. 1995 Jul 27;376(6538):348-51 PMID: 7630403
  33. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
    Leukemia. 1995 Aug;9(8):1305-12 PMID: 7643617
  34. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites.
    Cancer Res. 1995 Oct 1;55(19):4287-92 PMID: 7671237
  35. The leukemia-associated-protein (LAP) domain, a cysteine-rich motif, is present in a wide range of proteins, including MLL, AF10, and MLLT6 proteins.
    Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9737-41 PMID: 7568208
  36. An integrated physical map of human chromosome 16.
    Nature. 1995 Sep 28;377(6547 Suppl):335-65 PMID: 7566100
  37. Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases.
    Blood. 1995 Nov 1;86(9):3613-4 PMID: 7579475
  38. Altered Hox expression and segmental identity in Mll-mutant mice.
    Nature. 1995 Nov 30;378(6556):505-8 PMID: 7477409
  39. Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia.
    Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12160-4 PMID: 8618864
  40. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro.
    Oncogene. 1995 Dec 21;11(12):2509-14 PMID: 8545107
  41. Localization of human CREB-binding protein gene (CREBBP) to 16p13.2-p13.3 by fluorescence in situ hybridization.
    Genomics. 1995 Nov 20;30(2):395-6 PMID: 8586450
  42. Chromosomal translocations in secondary acute myeloid leukemia.
    N Engl J Med. 1996 Feb 29;334(9):601-3 PMID: 8569841
  43. CBP as a transcriptional coactivator of c-Myb.
    Genes Dev. 1996 Mar 1;10(5):528-40 PMID: 8598284
  44. An RNA polymerase II elongation factor encoded by the human ELL gene.
    Science. 1996 Mar 29;271(5257):1873-6 PMID: 8596958
  45. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation.
    Cell. 1996 Mar 22;84(6):843-51 PMID: 8601308
  46. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors.
    Blood. 1996 Apr 1;87(7):2649-58 PMID: 8639880
  47. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes.
    Cell. 1996 Jun 14;85(6):853-61 PMID: 8681380
  48. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
    Nature. 1996 Jul 25;382(6589):319-24 PMID: 8684459
  49. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.
    Nat Genet. 1996 Sep;14(1):33-41 PMID: 8782817
  50. The transcriptional coactivators p300 and CBP are histone acetyltransferases.
    Cell. 1996 Nov 29;87(5):953-9 PMID: 8945521
  51. The CBP co-activator is a histone acetyltransferase.
    Nature. 1996 Dec 19-26;384(6610):641-3 PMID: 8967953
  52. Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3.
    Genomics. 1997 May 15;42(1):96-114 PMID: 9177780
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1997-08-05
Pages
8732-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC23102
Subset
IM
Grants
NCI NIH HHS · CA17575 · United States
NCI NIH HHS · CA42557 · United States
NHGRI NIH HHS · HG00299 · United States
Databases
GENBANK
U47741
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]